Impact of total PSA, PSA doubling time and PSA velocity on detection rates of 11C-Choline positron emission tomography in recurrent prostate cancer

被引：0
|
作者：
Maxim Rybalov
Anthonius J. Breeuwsma
Anna M. Leliveld
Jan Pruim
Rudi A. Dierckx
Igle J. de Jong
机构：
[1] University Medical Center Groningen,Department of Urology
[2] University Medical Center Groningen,Department of Nuclear Medicine and Molecular Imaging
来源：
World Journal of Urology | 2013年 / 31卷
关键词：
C-Choline PET; Prostate cancer; Recurrence; PSA; Kinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：319 / 323
页数：4
相关论文
共 50 条
  • [11] PSA vs. PSA Doubling Time for Prediction of [11C]Choline PET/CT in Prostatectomized Prostate Cancer Patients with Biochemical Failure
    Giovacchini, G.
    Picchio, M.
    Parra, R. Garcia
    Scattoni, V.
    Gianolli, L.
    Messa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S172 - S172
  • [12] 11C-choline Predicits Survival In Prostate Cancer Patients With PSA < 1 ng/mL
    Giovacchini, G.
    Guglielmo, P.
    Incerti, E.
    Mapelli, P.
    Gajate, A. Samanes
    Giovannini, E.
    Riondato, M.
    Briganti, A.
    Gianolli, L.
    Ciarmiello, A.
    Picchio, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S536 - S536
  • [13] A Commentary on PSA Velocity and Doubling Time for Clinical Decisions in Prostate Cancer
    Vickers, Andrew J.
    Thompson, Ian M.
    Klein, Eric
    Carroll, Peter R.
    Scardino, Peter T.
    UROLOGY, 2014, 83 (03) : 592 - 596
  • [14] The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
    Paller, C. J.
    Olatoye, D.
    Xie, S.
    Zhou, X.
    Denmeade, S. R.
    Eisenberger, M. A.
    Antonarakis, E. S.
    Carducci, M. A.
    Rosner, G. L.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2014, 17 (01) : 28 - 33
  • [15] The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
    C J Paller
    D Olatoye
    S Xie
    X Zhou
    S R Denmeade
    M A Eisenberger
    E S Antonarakis
    M A Carducci
    G L Rosner
    Prostate Cancer and Prostatic Diseases, 2014, 17 : 28 - 33
  • [16] 11C-choline positron emission tomography in prostate cancer:: Primary staging and recurrent site staging
    Yoshida, S
    Nakagomi, K
    Goto, S
    Futatsubashi, M
    Torizuka, T
    UROLOGIA INTERNATIONALIS, 2005, 74 (03) : 214 - 220
  • [17] Correlation between 11C-Choline PET/CT detection rate and Trigger PSA in prostate cancer patients with an increase of PSA serum level after radical prostatectomy
    Fuccio, C.
    Santi, I.
    Castellucci, P.
    Montini, G.
    Schiavina, R.
    Martorana, G.
    Rizziello, A.
    Lodi, F.
    Pettinato, V.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S173 - S173
  • [18] PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/ml
    Djavan, B
    Zlotta, A
    Kratzik, C
    Remzi, M
    Seitz, C
    Schulman, CC
    Marberger, M
    UROLOGY, 1999, 54 (03) : 517 - 522
  • [19] Identification of High-Risk Prostate Cancer: Role of Prostate-Specific Antigen, PSA Doubling Time, and PSA velocity
    Heidenreich, Axel
    EUROPEAN UROLOGY, 2008, 54 (05) : 976 - 979
  • [20] Comparison of 11C-choline Positron Emission Tomography/Computed Tomography (PET/CT) and Conventional Imaging for Detection of Recurrent Prostate Cancer
    Kawanaka, Yusuke
    Kitajima, Kazuhiro
    Yamamoto, Shingo
    Nakanishi, Yukako
    Yamada, Yusuke
    Hashimoto, Takahiko
    Suzuki, Toru
    Go, Shuken
    Kanematsu, Akihiro
    Nojima, Michio
    Sofue, Keitaro
    Trsurusaki, Masakatsu
    Tamaki, Yukihisa
    Yoshida, Rika
    Yamakado, Koichiro
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2018, 10 (07)
12345